cbdMD (YCBD) Cash from Investing Activities (2016 - 2025)
cbdMD's (YCBD) quarterly Cash from Investing Activities came in at -$164802.0 in Q4 2025, little changed year-on-year from -$165219.1 in Q4 2024, and down 5777.39% quarter-over-quarter from -$2804.0 in Q3 2025.
cbdMD (YCBD) Cash from Investing Activities (2016 - 2025) Analysis & Trends
cbdMD has disclosed Cash from Investing Activities across 10 years of filings, most recently posting -$164802.0 for Q4 2025.
- Cash from Investing Activities for Q4 2025 came in at -$164802.0, changed 0.25% year-over-year; the trailing twelve-month figure through Dec 2025 was -$184587.0 (up 31.58% YoY), and the FY2025 annual result was -$184172.0, up 36.5% from the prior year.
- Cash from Investing Activities came in at -$164802.0 for Q4 2025 at cbdMD, down from -$2804.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $1.1 million in Q1 2023 to a low of -$2.0 million in Q3 2021.
- The 5-year median for Cash from Investing Activities is -$120180.0 (2023), against an average of -$190733.5.
- Peak annual rise in Cash from Investing Activities reached 921.25% in 2021, while the deepest fall reached 820.91% in 2021.
- cbdMD's Cash from Investing Activities stood at -$231030.0 in 2021, then advanced by 23.23% to -$177370.0 in 2022, then retreated by 4.1% to -$184635.0 in 2023, then climbed by 10.97% to -$164387.0 in 2024, then retreated by 0.25% to -$164802.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$164802.0 (Q4 2025), -$2804.0 (Q3 2025), and -$1475.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.45 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 25.99 Mn |
| 10 | cbdMD | 3,884.57 | -3.38 Mn | 3.00 Mn | -164,802.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -164,802.00 |
| Dec 31, 2025 | -164,802.00 |
| Sep 30, 2025 | -2,804.00 |
| Sep 30, 2025 | -2,804.00 |
| Jun 30, 2025 | -1,475.00 |
| Jun 30, 2025 | -1,475.00 |
| Mar 31, 2025 | -15,506.00 |
| Mar 31, 2025 | -15,506.00 |
| Dec 31, 2024 | -164,387.00 |
| Dec 31, 2024 | -164,387.00 |
| Sep 30, 2024 | -110,000.00 |
| Sep 30, 2024 | -110,000.00 |
| Mar 31, 2024 | 4,620.00 |
| Mar 31, 2024 | 4,620.00 |
| Dec 31, 2023 | -184,635.00 |
| Dec 31, 2023 | -184,635.00 |
| Sep 30, 2023 | -120,180.00 |
| Sep 30, 2023 | -120,180.00 |
| Jun 30, 2023 | -102,389.00 |
| Jun 30, 2023 | -102,389.00 |